Aida Sacaan
About
Aida Sacaan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology.
According to data from OpenAlex, Aida Sacaan has authored 52 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 8 papers in Pharmacology. Recurrent topics in Aida Sacaan's work include Neuroscience and Neuropharmacology Research (24 papers), Nicotinic Acetylcholine Receptors Study (13 papers) and Receptor Mechanisms and Signaling (12 papers). Aida Sacaan is often cited by papers focused on Neuroscience and Neuropharmacology Research (24 papers), Nicotinic Acetylcholine Receptors Study (13 papers) and Receptor Mechanisms and Signaling (12 papers). Aida Sacaan collaborates with scholars based in United States, Switzerland and Norway. Aida Sacaan's co-authors include Darryle D. Schoepp, Kenneth M. Johnson, Emily M. Santori, G. Kenneth Lloyd, Gönül Veliçelebi, Sara Rao, Edwin C. Johnson, Mark A. Varney, Stephen D. Hess and Peter J. Flor and has published in prestigious journals such as Cancer Research, Brain Research and Clinical Cancer Research.
In The Last Decade
Aida Sacaan
51 papers receiving 2.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aida Sacaan United States | 24 | 1.8k | 1.6k | 281 | 205 | 190 | 52 | 2.5k | ||
| John L. Musachio United States | 31 | 1.2k 0.7× | 1.8k 1.1× | 152 0.5× | 250 1.2× | 359 1.9× | 80 | 3.0k | ||
| M.C. Dubroeucq France | 18 | 1.4k 0.8× | 925 0.6× | 220 0.8× | 175 0.9× | 261 1.4× | 24 | 2.0k | ||
| C. Guérémy France | 25 | 1.7k 1.0× | 1.3k 0.8× | 265 0.9× | 216 1.1× | 160 0.8× | 51 | 2.6k | ||
| Patricia C. Contreras United States | 30 | 1.4k 0.8× | 1.5k 1.0× | 224 0.8× | 197 1.0× | 111 0.6× | 58 | 2.7k | ||
| Christopher J. Langmead Australia | 33 | 1.9k 1.1× | 3.0k 1.9× | 264 0.9× | 202 1.0× | 274 1.4× | 85 | 4.0k | ||
| Georgina Rodrı́guez de Lores Arnaiz Argentina | 25 | 1.6k 0.9× | 1.7k 1.1× | 125 0.4× | 336 1.6× | 293 1.5× | 107 | 2.8k | ||
| Julianna Kardos Hungary | 22 | 1.3k 0.7× | 1.1k 0.7× | 318 1.1× | 371 1.8× | 107 0.6× | 117 | 2.3k | ||
| C. Renault France | 18 | 1.3k 0.7× | 957 0.6× | 191 0.7× | 176 0.9× | 109 0.6× | 25 | 1.9k | ||
| Rajender K. Kamboj United States | 21 | 917 0.5× | 865 0.5× | 186 0.7× | 187 0.9× | 62 0.3× | 40 | 1.6k | ||
| Matthew A. Sills United States | 29 | 1.4k 0.8× | 1.7k 1.1× | 95 0.3× | 351 1.7× | 219 1.2× | 72 | 3.0k |
Countries citing papers authored by Aida Sacaan
Since
Specialization
Citations
This map shows the geographic impact of Aida Sacaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aida Sacaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aida Sacaan more than expected).
Fields of papers citing papers by Aida Sacaan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Aida Sacaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aida Sacaan. The network helps show where Aida Sacaan may publish in the future.
Co-authorship network of co-authors of Aida Sacaan
This figure shows the co-authorship network connecting the top 25 collaborators of Aida Sacaan. A scholar is included among the top collaborators of Aida Sacaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aida Sacaan. Aida Sacaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Anders, Lars, Todd Van Arsdale, Sudhakar Chintharlapalli, et al.. (2024). 354P Synergistic preclinical efficacy through combination of the CDK4 and CDK2 selective inhibitors, PF-07220060 and PF-07104091, respectively, in HR+ HER2- breast cancer. Annals of Oncology. 35. S365–S365.
2.
Vitsky, Allison, Aida Sacaan, Wenyue Hu, Martin B. Finkelstein, & William J. Reagan. (2022). Gemtuzumab Ozogamicin Treatment Results in Decreased Proliferation and Differentiation of Human Megakaryocytes but Does Not Inhibit Mature Platelet Function. Toxicologic Pathology. 50(7). 871–880.
3.
Catlin, Natasha R., Christopher Bowman, Aida Sacaan, et al.. (2019). Reproductive and developmental toxicity assessment of palbociclib, a CDK4/6 inhibitor, in Sprague-Dawley rats and New Zealand White rabbits. Reproductive Toxicology. 88. 76–84.
4.
Thibault, Stéphane, Wenyue Hu, Brad Hirakawa, et al.. (2018). Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary Pharmacology. Molecular Cancer Therapeutics. 18(2). 257–266.
5.
Buckley, Lorrene A., et al.. (2018). Pharmaceutical industry perspective on combination toxicity studies: Results from an intra-industry survey conducted by IQ DruSafe Leadership Group. Regulatory Toxicology and Pharmacology. 102. 40–46.
6.
Hu, Wenyue, Tae Sung, Bart Jessen, et al.. (2015). Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies. Clinical Cancer Research. 22(8). 2000–2008.
7.
Huang, Wenhu, et al.. (2015). Application of electroretinography (ERG) in early drug development for assessing retinal toxicity in rats. Toxicology and Applied Pharmacology. 289(3). 525–533.
8.
Rao, Tadimeti S., Lucia Correa, Emily M. Santori, et al.. (2003). In vitro pharmacological characterization of (±)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand. Brain Research. 981(1-2). 85–98.
9.
Gasparini, F., Kurt Lingenhöhl, Natacha Stoehr, et al.. (1999). 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology. 38(10). 1493–1503.
10.
Lloyd, G. Kenneth, Frédérique Menzaghi, Bruno Bontempi, et al.. (1998). The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sciences. 62(17-18). 1601–1606.
11.
Vernier, Jean‐Michel, Nicholas D. P. Cosford, Jeffrey P. Whitten, et al.. (1998). Conformationally restricted analogues of nicotine and anabasine. Bioorganic & Medicinal Chemistry Letters. 8(16). 2173–2178.
12.
Elliott, Kathryn, et al.. (1998). 6-hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression. Journal of Molecular Neuroscience. 10(3). 251–260.
13.
Phelan, Kevin D., Aida Sacaan, & Joel P. Gallagher. (1996). Retrograde labeling of rat dorsolateral septal nucleus neurons following intraseptal injections of WGA-HRP. Synapse. 22(3). 261–268.
14.
Sacaan, Aida, Julia Dunlop, & G. Kenneth Lloyd. (1995). Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.. Journal of Pharmacology and Experimental Therapeutics. 274(1). 224–230.
15.
Daggett, Lorrie P., Aida Sacaan, M. Akong, et al.. (1995). Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5. Neuropharmacology. 34(8). 871–886.
16.
Schoepp, Darryle D., David Lodge, John D. Millar, et al.. (1991). D,L-(Tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist. European Journal of Pharmacology. 203(2). 237–243.
17.
Sacaan, Aida & Kenneth M. Johnson. (1991). Regulation of polyamine and magnesium inhibition of the (NMDA) receptor ionophore complex. Neuroscience Letters. 121(1-2). 219–222.
18.
Sacaan, Aida & Kenneth M. Johnson. (1990). Characterization of the stimulatory and inhibitory effects of polyamines on [3H]N-(1-[thienyl]cyclohexyl) piperidine binding to the N-methyl-D-aspartate receptor ionophore complex.. Molecular Pharmacology. 37(4). 572–577.
19.
Abdul‐Ghani, Abdul‐Salam, et al.. (1989). Changes in the Activity of Glutamate Related Enzymes in Cerebral Cortex, During Insulin-Induced Seizures. International Journal of Neuroscience. 44(1-2). 67–74.
20.
Ferkany, John W., Donald J. Kyle, Jonathon M. Willets, et al.. (1989). Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 100–109.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by John L. Musachio Breakdown of academic impact, for papers by M.C. Dubroeucq Breakdown of academic impact, for papers by C. Guérémy Breakdown of academic impact, for papers by Patricia C. Contreras Breakdown of academic impact, for papers by Christopher J. Langmead Breakdown of academic impact, for papers by Georgina Rodrı́guez de Lores Arnaiz Breakdown of academic impact, for papers by Julianna Kardos Breakdown of academic impact, for papers by C. Renault Breakdown of academic impact, for papers by Rajender K. Kamboj Breakdown of academic impact, for papers by Matthew A. Sills